BEATRIX Study on Group B Streptococcus Vaccine in Pregnant Women Initiates Recruitment
The BEATRIX study is enrolling healthy pregnant women to evaluate the safety and efficacy of GBS vaccine.
Asset / Drug
Drug and asset intelligence for BEATRIX with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
Vaccine
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.